In part 6, Prof. Caplan discusses Trophic properties of mesenchymal stem cells; MSCs for heart disease; MSCs homing to heart injury site and also to skin incision site; MSCs limit left ventricular thinning following infarction; Trophic properties of MSCs: anti-apoptotic, anti-fibrotic, anti-scarring, angiogenic, mitotic; phase 1 data for allogeneic MSCs show fewer arrhythmias, prompt heart [...]
SAN DIEGO, CA and PORTLAND, OR, Mar 05, 2012 (MARKETWIRE via COMTEX) -- Medistem Inc. (pinksheets:MEDS), in partnership with its Russian licensee, ERCell, announced the signing of a letter of intent* to begin clinical trials using Medistem's Endometrial Regenerative Cells (ERC) stem cells for renal, lung and peripheral artery disease. Trials will be conducted in [...]
Yang et al. Clin Toxicol (Phila). 2011 Apr;49(4):298-302. Paraquat is a herbicide that is linked to development of Parkinsons. It also is a toxin to lung cells and is used as a model of inducing lung injury in rats. In the current study the investigators wanted to see if administration of bone marrow mesenchymal stem [...]
Researchers from the University of California San Francisco presented data today at the ATS 2010 International Conference in New Orleans demonstrating activity of adult stem cells in treatment of acute lung injury. This is a common condition in intensive care units that causes respiratory failure and often leads to death. The cause of acute lung [...]
According to an article IndianExpress.com, an international patent has been issued to the G R Doshi K M Mehta Institute of Kidney Diseases and Research Centre (IKDRC) and Dr HL Trivedi Institute of Transplantation Sciences (ITS) from Ahmedabad, Indian for utilization of stem cells in treatment of patients having undergone kidney transplantation. Given that we [...]